Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Could Detect Abusive Head Trauma in Infants

By LabMedica International staff writers
Posted on 26 Apr 2017
A blood test has been developed and refined that could help clinicians identify infants who may have had bleeding of the brain as a result of abusive head trauma, sometimes referred to as shaken baby syndrome.

Approximately 30% of abusive head trauma (AHT) diagnoses are missed when caretakers provide inaccurate histories or when infants have nonspecific symptoms such as vomiting or fussiness. More...
Missed diagnoses can be catastrophic as AHT can lead to permanent brain damage and even death.

A team of scientists working with the Children's Hospital of Pittsburgh performed a retrospective study on a cohort of 99 patients followed by a prospective cohort of 599 patients to derive and validate the Biomarkers of Infant Brain Injury Score. The Biomarkers of Infant Brain Injury Score predicted intracranial hemorrhage with a higher sensitivity than clinical judgment, the current criterion standard.

Binary logistic regression was used to develop a multivariable model incorporating three serum biomarkers, matrix metallopeptidase-9, neuron-specific enolase, and vascular cellular adhesion molecule-1, and one clinical variable, total hemoglobin. The model was then prospectively validated. Multiplex biomarker measurements were performed using Flow-Thru microarray technology on the Ziplex System, which has potential as a point-of-care system. The Axela's automated testing system allowed the researchers to measure multiple biomarkers simultaneously using an extremely small amount of blood, an important characteristic of a test designed to be used in infants.

The test correctly detected acute intracranial hemorrhage because of abusive head trauma approximately 90% of the time, a much higher rate than the sensitivity of clinical judgement, which is approximately 70%. The specificity of the test was 48% and the sensitivity was 89.3%. The team aimed for the test to be highly sensitive rather than maximizing accuracy, since missing a diagnosis has more serious consequences than performing brain imaging in babies without the condition.

The authors concluded that The Biomarkers for Infant Brain Injury Score, a multivariable model using three serum biomarker concentrations and serum hemoglobin, can identify infants with acute intracranial hemorrhage. Rachel Pardes Berger, MD, MPH, a senior author of the study, said, “The test is not intended to replace clinical judgement, which is crucial. Rather, we believe that it can supplement clinical evaluation and in cases where symptoms may be unclear, help physicians make a decision about whether an infant needs brain imaging.” The study was published on April 10, 2017, in the journal JAMA Pediatrics.


Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
ESR Analyzer
TEST1 2.0
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.